Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cell transplantation for diabetic neuropathy
IRCT201103171414N23Phase 3Completed
- Sponsor
- ٍٍٍEndocrinology & Metabolism Research Institute Tehran University Of Medical Sciences
- Start
- Jun 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3 trial of mesenchymal stem cells in diabetic neuropathy and type 2 diabetes mellitus (T2DM), sponsored by ٍٍٍEndocrinology & Metabolism Research Institute Tehran University Of Medical Sciences. Started Jun 2012; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
diabetic neuropathytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT201103171414N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201103171414N23.